Utrecht Health Seed Fund

Overview

Utrecht Health Seed Fund is a venture capital firm based in the Netherlands, focusing on early-stage investments in health and life sciences startups. The fund primarily invests in scalable technologies within Life Sciences, including therapeutics and diagnostics, Medical Devices, Digital Health, and Animal Health. Their investment approach involves providing initial funding ranging from €100,000 to €250,000, typically through convertible loans or equity investments. The fund emphasizes co-investing alongside other established funds to offer startups a robust financial foundation. The fund's investment strategy targets companies in the pre-seed to Series B stages, with a particular emphasis on the pre-seed and seed stages. It operates within the Netherlands, aligning with the country's strong emphasis on health and life sciences innovation. The fund's portfolio includes a diverse range of companies, such as Cordys Analytics, a healthtech startup specializing in AI-powered ECG analysis, and anDREa, a collaboration between multiple university hospitals focusing on Azure DRE development. Utrecht Health Seed Fund is managed by Utrecht Holdings, the knowledge transfer office of Utrecht University and UMC Utrecht. This management structure ensures a deep connection with academic and medical research, facilitating the identification and support of promising startups emerging from these institutions. The fund's commitment to fostering innovation is further demonstrated by its active participation in initiatives like the HealthTech Investor Summit, which connects European healthtech entrepreneurs with investors and industry leaders.

Investment Focus

• Technological innovation in healthcare
• Strong entrepreneurship
• Seed and Growth stage
• Attractive financial profile and growth opportunities

Portfolio Companies